Table 1.
Participant characteristics at baseline (n=11).
| Age (years) | 56.9 (7.9) |
|---|---|
| Race (%) | |
| Caucasian | 90 |
| African-American | 10 |
| Mass (kg) | 74.2 (14.8) |
| Height (cm) | 165.3 (4.6) |
| Body mass index (kg/m2) | 27.3 (6.5) |
| Body fat percentage (%) | 40.7 (5.6) |
| Some college degree (%) | 90 |
| Time since diagnosis (months) | 8.2 (3.5) |
| Time since completion of initial treatments (months) | 2.5 (2.2) |
| Disease stage (%) | |
| I | 30 |
| II | 60 |
| III | 10 |
| ER+ (%) | 90 |
| HER2+ (%) | 20 |
| Post menopause (%) | 60 |
| Radiation therapy (%) | 70 |
| Chemotherapy (%) | 60 |
| Hormone therapy (%) | 82 |
| Surgery (%) | |
| Mastectomy | 30 |
| Lumpectomy | 70 |
Data presented as mean (SD); ER, estrogen receptor; HER2, human epidermal growth factor receptor 2.